Last reviewed · How we verify

NCT03675646

Spinal Morphine for Postoperative Analgesia in Urology

Completed Phase 4 Last updated 19 September 2018
What this trial tests

Phase 4 trial testing Morphine in Pain, Postoperative in 98 participants. Completed in 10 July 2017.

Timeline
5 March 2016
Primary endpoint
30 June 2017
10 July 2017

Quick facts

Lead sponsorCharles University, Czech Republic
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposetreatment
Enrollment98
Start date5 March 2016
Primary completion30 June 2017
Estimated completion10 July 2017
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Charles University, Czech Republic

Who can join

18 and older, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was performed in urology patients elicited for open prostatectomy or open nephrectomy. Comparison of analgesic effect between group (M) with spinal morphine before general anaesthesia and group without this intervention was measured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Intrathecal hydrophilic opioids for abdominal surgery: a meta-analysis, meta-regression, and trial sequential analysis.
    Koning MV, Klimek M, Rijs K, Stolker RJ, et al · · 2020 · cited 53× · PMID 32660719 · DOI 10.1016/j.bja.2020.05.061

Verify or expand the search:

Other trials of Morphine

Trials testing the same drug.

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Charles University, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03675646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing